Pilot Study in Patients With Symptomatic Steroid-Naive Asthma
A Phase I/II, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Pilot Study of SB 240683 in Patients With Symptomatic Steroid-Naive Asthma
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment
Enrollment
Phase
Phase
- Phase 2
Contacts and Locations
Study Locations
-
-
California
-
Los Angeles, California, United States, 90025
- Allergy Research Foundation
-
Mission Viejo, California, United States, 92691
- Southern California Research
-
Orange, California, United States, 92868
- Clinical Trials of Orange Cnty., Inc.
-
San Diego, California, United States, 92120
- Allergy Associates Medical Group, Inc.
-
San Jose, California, United States, 95117
- Allergy and Asthma Associates Santa Clara Valley Research Center
-
Stockton, California, United States, 95207
- Bensch Research Associates
-
-
Colorado
-
Denver, Colorado, United States, 80206
- National Jewish Medical and Research Center
-
-
Illinois
-
Normal, Illinois, United States, 61761
- ICSL Clinical Studies
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02115
- Respiratory Therapy and Pulmonary Clinical Research Brigham & Women's Hospital
-
N. Dartmouth, Massachusetts, United States, 02747
- New England Clinical Studies
-
-
Minnesota
-
Minneapolis, Minnesota, United States, 55402
- Clinical Research Institute
-
-
Missouri
-
St. Louis, Missouri, United States, 63141
- The Clinical Research Center, LLC
-
-
Nebraska
-
Omaha, Nebraska, United States, 68131
- Center for Allergy, Asthma and Immunology, Creighton University
-
-
New Jersey
-
Princeton, New Jersey, United States, 08540
- Princeton Center For Clinical Research
-
-
Oregon
-
Lake Oswego, Oregon, United States, 97035
- Allergy, Asthma, and Dermatology Research Center, LLC
-
-
Pennsylvania
-
Easton, Pennsylvania, United States, 18045
- Valley Clinical Research Center
-
-
Texas
-
Houston, Texas, United States, 77090
- Clinical Trials North Houston
-
-
Wisconsin
-
Madison, Wisconsin, United States, 53792
- University of Wisconsin Medical School
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- At least a 6-month history of asthma
- No use of inhaled, oral or injectable steroids for at least 1 month prior to enrollment
Exclusion Criteria:
- Patients with > 10 pack years of smoking history or smoking within 12 months of study enrollment
- No significant disease other than asthma
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Estimate)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 683-803
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.